ENDRA Life Sciences Inc
NDRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.68M
Close$
$0.34
92.3% downside
Current Fair Value
92.3% downsideOvervalued by 92.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.68 Million |
|---|---|
| Enterprise Value | $4.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.93 |
| Beta | -0.07 |
| Outstanding Shares | 1,324,046 |
Return
| Return on Equity | -93.77% |
|---|---|
| Return on Assets | -74.50% |
| Return on Invested Capital | -22.30% |
Valuation & Multiples
| P/E Ratio | -0.71 |
|---|---|
| PEG | 0.62 |
| Price to Sales | - |
| Price to Book Ratio | 1.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.74 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.84
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-1.14
Average shareholder expectationRevenue Estimate
$100,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ENDRA Life Sciences Inc
18 employees